Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 134

Similar articles for PubMed (Select 18429707)

1.

Ensuring the safety of new medications and devices: are naltrexone implants safe?

Wodak AD, Ali R, Henry D, Sansom L.

Med J Aust. 2008 Apr 21;188(8):438-9. No abstract available.

PMID:
18429707
2.

Trichotillomania successfully treated with risperidone and naltrexone: a geriatric case report.

Oravecz R, Štuhec M.

J Am Med Dir Assoc. 2014 Apr;15(4):301-2. doi: 10.1016/j.jamda.2014.01.007. Epub 2014 Mar 2. No abstract available.

PMID:
24598474
3.

Naltrexone therapy for Crohn's disease and ulcerative colitis.

Weinstock LB.

J Clin Gastroenterol. 2014 Sep;48(8):742. doi: 10.1097/MCG.0000000000000093. No abstract available.

PMID:
24583747
4.

[L.S. Stavseth and colleagues reply].

Stavseth LS, Tanum L, Kunøe N.

Tidsskr Nor Laegeforen. 2014 Jan 28;134(2):136-7. doi: 10.4045/tidsskr.13.1669. Norwegian. No abstract available.

5.

[Violation of the Helsinki Declaration].

Ekgren JS.

Tidsskr Nor Laegeforen. 2014 Jan 28;134(2):136. doi: 10.4045/tidsskr.13.1668. Norwegian. No abstract available.

6.

[Registered opiate addicts in Norway].

Pedersen E.

Tidsskr Nor Laegeforen. 2014 Jan 28;134(2):136. doi: 10.4045/tidsskr.13.1667. Norwegian. No abstract available.

7.

[Long-acting naltrexone--a new way out of opiate addiction?].

Stavseth LS, Kunøe N, Tanum L.

Tidsskr Nor Laegeforen. 2013 Nov 12;133(21):2231-2. doi: 10.4045/tidsskr.13.1139. Norwegian. No abstract available.

8.

Commentary on Krupitsky et al.(2013): Refuge from the streets--parked on methadone, or seeking shelter of a depot?

Bell J.

Addiction. 2013 Sep;108(9):1638-9. doi: 10.1111/add.12248. No abstract available.

PMID:
23947734
9.

Avoiding narcotics in Crohn's disease.

Jackson WE, Rizk M, Lashner BA.

J Clin Gastroenterol. 2013 Apr;47(4):293-5. doi: 10.1097/MCG.0b013e318278aeec. No abstract available.

PMID:
23426445
10.

Commentary on Kelty & Hulse (2012): is the comparison of mortality between patients prescribed implanted or oral naltrexone an unbiased and unconfounded comparison?

Hickman M, Degenhardt L, Farrell M, Hall W.

Addiction. 2012 Oct;107(10):1825-6. doi: 10.1111/j.1360-0443.2012.03966.x. No abstract available.

PMID:
22962958
11.

[The use of different forms of naltrexone in the treatment of opioid dependence].

Krupitskiĭ EM, Zvartau EE, Blokhina EA, Woody G.

Zh Nevrol Psikhiatr Im S S Korsakova. 2011;111(11 Pt 2):66-72. Russian.

PMID:
22611701
12.

A 'miracle cure' misunderstood.

Brewer C.

Addiction. 2012 Aug;107(8):1528. doi: 10.1111/j.1360-0443.2012.03912.x. Epub 2012 May 17. No abstract available.

PMID:
22594709
13.

Injectable extended-release naltrexone for opioid dependence.

Throckmorton DC, Temple R, Rappaport BA, Roca R, Winchell CJ.

Lancet. 2011 Aug 20;378(9792):665-6; author reply 666. doi: 10.1016/S0140-6736(11)61332-9. No abstract available.

PMID:
21856478
14.

Injectable extended-release naltrexone for opioid dependence.

Krupitsky E, Nunes EV, Ling W, Illeperuma A, Gastfriend DR, Silverman BL.

Lancet. 2011 Aug 20;378(9792):665; author reply 666. doi: 10.1016/S0140-6736(11)61331-7. No abstract available.

PMID:
21856477
15.

Injectable extended-release naltrexone for opioid dependence.

Woody GE, Metzger DS.

Lancet. 2011 Aug 20;378(9792):664-5; author reply 666. doi: 10.1016/S0140-6736(11)61330-5. No abstract available.

PMID:
21856476
16.

Promise of extended-release naltrexone is a red herring.

Bart G.

Lancet. 2011 Aug 20;378(9792):663; author reply 663-4. doi: 10.1016/S0140-6736(11)61328-7. No abstract available.

PMID:
21856474
17.

[Low dosage naltrexone].

Raknes G, Giverhaug T.

Tidsskr Nor Laegeforen. 2011 Aug 9;131(15):1415-6. doi: 10.4045/tidsskr.11.0651. Norwegian. No abstract available.

18.

[Research on low dosage naltrexone].

Holmøy T.

Tidsskr Nor Laegeforen. 2011 Jul 1;131(13-14):1277-8. doi: 10.4045/tidsskr.11.0578. Norwegian. No abstract available.

19.

Concerns about injectable naltrexone for opioid dependence.

Wolfe D, Carrieri MP, Dasgupta N, Wodak A, Newman R, Bruce RD.

Lancet. 2011 Apr 30;377(9776):1468-70. doi: 10.1016/S0140-6736(10)62056-9. No abstract available.

PMID:
21529930
20.

Pharmacokinetic drug interactions and adverse consequences between psychotropic medications and pharmacotherapy for the treatment of opioid dependence.

Saber-Tehrani AS, Bruce RD, Altice FL.

Am J Drug Alcohol Abuse. 2011 Jan;37(1):1-11. doi: 10.3109/00952990.2010.540279. Review.

PMID:
21247284
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk